THY1 and hepatocellular carcinoma: In a subsequent study, same authors detected CD45- CD90+ CD44+ CTCs in 68.3% of enrolled HCC patients, demonstrating a significant correlation with tumor size, TNM stage and, more relevantly, with post-hepatectomy recurrence and survival.